Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Literature DB >> 19454426

Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

H Tilly¹, M Dreyling.

Abstract

Entities: Disease

Mesh：

Year: 2009 PMID： 19454426 DOI： 10.1093/annonc/mdp145

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Diffuse large B cell lymphoma: cutaneous manifestation.

Authors: Rakesh Sajjan; Athar Haroon; Ziauddin Saad; Irfan Kayani
Journal: BMJ Case Rep Date: 2011-11-15

2. The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02.

Authors: Jeong Won Lee; Dongryul Oh; Keun-Yong Eom; Jin Hee Kim; Woo Chul Kim; Mi Joo Chung; Jong Hoon Lee
Journal: Clin Exp Metastasis Date: 2019-09-25 Impact factor: 5.150

Review 3. Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Authors: Sarah Barton; Eliza A Hawkes; Andrew Wotherspoon; David Cunningham
Journal: Oncologist Date: 2012-10-18

4. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma.

Authors: Basem Magdy William; Navneeth Rao Bongu; Martin Bast; Robert Gregory Bociek; Philip Jay Bierman; Julie Marie Vose; James Olen Armitage
Journal: Rev Bras Hematol Hemoter Date: 2013

Review 5. Relevance of miR-21 in HIV and non-HIV-related lymphomas.

Authors: Durairaj Sekar; Villianur Ibrahim Hairul Islam; Krishnaraj Thirugnanasambantham; Subramanian Saravanan
Journal: Tumour Biol Date: 2014-06-25

6. A study of clinical characteristicsof mediastinal mass.

Authors: Akshatha Rao Aroor; Rama Prakasha S; Shubha Seshadri; Teerthanath S; Uppoor Raghuraj
Journal: J Clin Diagn Res Date: 2014-02-03

7. The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.

Authors: Wojciech Jurczak; Elżbieta Kisiel; Joanna Sawczuk-Chabin; Piotr Centkowski; Wanda Knopińska-Posłuszny; Omeir Khan
Journal: Contemp Oncol (Pozn) Date: 2015-03-26